During the past decade, SGS Biopharma Research Unit Stuivenberg conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "SGS Biopharma Research Unit Stuivenberg" are "Encephalitis, Tick-borne" (2 trials), "HIV Infections" (1 trials) and "HIV-1" (1 trials). Many other conditions were trialed in "SGS Biopharma Research Unit Stuivenberg" in a lesser frequency.

Most popular intervention types in "SGS Biopharma Research Unit Stuivenberg" are "Biological" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Formaldehyde inactivated, sucrose gradient purified TBE virus antigen, strain Neudörfl" (1 trials), "Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)" (1 trials) and "dapivirine (TMC120) vaginal gel" (1 trials). Other intervention names were less common.

The vast majority of trials in "SGS Biopharma Research Unit Stuivenberg" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "SGS Biopharma Research Unit Stuivenberg". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in SGS Biopharma Research Unit Stuivenberg, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SGS Biopharma Research Unit Stuivenberg, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".